Erianin inhibits indoleamine 2, 3-dioxygenase -induced tumor angiogenesis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biopha.2017.01.090PMID 28129624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IDO in Inflammatory Programming and Immune Suppression in Cancer

  2014cited by this paper
• Synstatin: a selective inhibitor of the syndecan‐1‐coupled IGF1R–αvβ3 integrin complex in tumorigenesis and angiogenesis

  2013cited by this paper
• Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion.

  2011cited by this paper
• Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

  2011cited by this paper
• Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials.

  2008cited by this paper
• Effect of AMG 479 on anti-tumor effects of gemcitabine and erlotinib against pancreatic carcinoma xenograft models

  2008cited by this paper
• Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.

  2006cited by this paper
• Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute.

  2006cited by this paper
• Ido expression by dendritic cells: tolerance and tryptophan catabolism

  2004cited by this paper
• In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent.

  2004cited by this paper
• Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

  2003cited by this paper
• Antioxidative activity of natural products from plants.

  2000cited by this paper
• The Activity of Erianin and Chrysotoxine from Dendrobium chrysotoxum to Reverse Multidrug Resistance in B16/h MDR-1 Cells

  1998cited by this paper
• Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.

  1997cited by this paper
• Isolation and Antibacterial Activity of Marchantin A, a Cyclic Bis(bibenzyl) Constituent of Hungarian Marchantia polymorpha

  1995cited by this paper
• Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.

  1986cited by this paper
• ANTI‐PROSTATIC ACTIVITY OF BIFLURANOL, A FLUORINATED BIBENZYL

  1980cited by this paper

• Erianin protects chondrocytes against IL-1β-induced oxidative stress and ferroptosis by activating GPX4/STING signaling in osteoarthritis

  2026cites this paper
• Employing network pharmacology and molecular docking to explore the anti-gastric cancer mechanisms of Dendrobium Nobile, Dendrobium Chrysotoxum, and Dendrobium Fimbriatum

  2026cites this paper
• The Kynurenine Pathway and Indole Pathway in Tryptophan Metabolism Influence Tumor Progression

  2025cites this paper
• Erianin Disturbs Iron and ROS Homeostasis To Trigger Ferroptosis in Colorectal Cancer Cells.

  2025cites this paper
• Recent Research Progress on the Origin, Biological Activities, and Synthesis of Natural Bibenzyls.

  2025cites this paper
• A Dendrobium chrysotoxum extract erianin induce AML cells death by activating PPARɑ and downregulating PI3K/AKT signaling pathways.

  2025cites this paper
• Erianin Protects Human Umbilical Vein Endothelial Cells From Oxidized Low‐Density Lipoprotein‐Induced Apoptosis and Oxidative Stress Through Activation of Nuclear Factor E2‐Related Factor 2 Signaling

  2025cites this paper
• Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies

  2025cites this paper
• Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.

  2024cites this paper
• Erianin alleviates LPS-induced acute lung injury via antagonizing P-selectin-mediated neutrophil adhesion function.

  2024cites this paper
• TCM targets ferroptosis: potential treatments for cancer

  2024cites this paper
• Research progress on the pharmacological mechanism, in vivo metabolism and structural modification of Erianin.

  2024cites this paper
• From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer

  2024cites this paper
• Erianin inhibits tumor growth by promoting ferroptosis and inhibiting invasion in hepatocellular carcinoma through the JAK2/STAT3/SLC7A11 pathway

  2024cites this paper
• Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology

  2024cites this paper
• Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo

  2024cites this paper
• Erianin inhibits the progression of pancreatic cancer by directly targeting AKT and ASK1

  2024cites this paper
• Integrated metabolomic and transcriptomic analyses of Dendrobium chrysotoxum and D. thyrsiflorum reveal the biosynthetic pathway from gigantol to erianin

  2024cites this paper
• Research progress on the regulatory and pharmacological mechanism of chemical components of Dendrobium

  2024cites this paper
• Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance

  2024cites this paper
• IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma

  2024cites this paper
• The cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance.

  2024cites this paper
• The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy

  2023cites this paper
• Recent advances of antitumor leading compound Erianin: Mechanisms of action and structural modification.

  2023cites this paper
• The multifaceted roles of matrix metalloproteinases in lung cancer

  2023cites this paper
• Erianin: A phytoestrogen with therapeutic potential

  2023cites this paper
• Molecular mechanisms underlying the anticancer property of Dendrobium in various systems of the human body: A review.

  2023cites this paper
• Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification

  2023cites this paper
• In Silico Analysis of the Apoptotic and HPV Inhibitory Roles of Some Selected Phytochemicals Detected from the Rhizomes of Greater Cardamom

  2022cites this paper
• Erianin Controls Collagen-Mediated Retinal Angiogenesis via the RhoA/ROCK1 Signaling Pathway Induced by the alpha2/beta1 Integrin-Collagen Interaction

  2022cites this paper
• Ethoxy-erianin phosphate and afatinib synergistically inhibit liver tumor growth and angiogenesis via regulating VEGF and EGFR signaling pathways.

  2022cites this paper
• Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology

  2022influential citation
• Radiosynthesis and tumor microPET/CT imaging of 18F-fluoroethoxylerianin, a 18F-Labeled Erianin Analogue

  2022cites this paper
• Inhibiting STAT3 Signaling Pathway by Natural Products for Cancer Prevention and Therapy: In Vitro and In Vivo Activity and Mechanisms of Action.

  2022cites this paper
• IDO/kynurenine pathway in cancer: possible therapeutic approaches

  2022cites this paper
• Recent Research Progress on Natural Stilbenes in Dendrobium Species

  2022cites this paper
• Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity

  2021cites this paper
• The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo

  2021cites this paper
• The effect and mechanism of erianin on the reversal of oxaliplatin resistance in human colon cancer cells

  2021cites this paper
• Kynurenines as a Novel Target for the Treatment of Malignancies

  2021cites this paper
• Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway

  2021cites this paper
• Traditionally Used Medicinal Dendrobium: A Promising Source of Active Anticancer Constituents

  2020cites this paper
• Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer

  2020cites this paper
• Erianin Induces Apoptosis and Autophagy in Oral Squamous Cell Carcinoma Cells.

  2020cites this paper
• Interfering Human Papillomavirus E6/E7 Oncogenes in Cervical Cancer Cells Inhibits the Angiogenesis of Vascular Endothelial Cells via Increasing miR-377 in Cervical Cancer Cell-Derived Microvesicles

  2020cites this paper
• OTT_A_239979 4145..4155

  2020cites this paper
• DDDT_A_259006 3301..3313

  2020cites this paper
• Therapeutic potential of p53 reactivation in cervical cancer.

  2020cites this paper
• Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity.

  2020cites this paper
• OTT_A_200161 5457..5465

  2019cites this paper
• The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer

  2019cites this paper
• Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target

  2019cites this paper
• Picroside II, an iridoid glycoside from Picrorhiza kurroa, suppresses tumor migration, invasion, and angiogenesis in vitro and in vivo.

  2019cites this paper
• Vascular alteration in relation to fosfomycine: In silico and in vivo investigations using a chick embryo model.

  2019cites this paper
• Progressive study of effects of erianin on anticancer activity

  2019cites this paper
• Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells via ROS-Mediated JNK/c-Jun and AKT/mTOR Signaling Pathways

  2019cites this paper
• MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1

  2019cites this paper
• Biological and anti‐vascular activity evaluation of ethoxy‐erianin phosphate as a vascular disrupting agent

  2019cites this paper
• Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma.

  2019cites this paper
• Targeting indoleamine‐2,3‐dioxygenase in cancer: Scientific rationale and clinical evidence

  2019cites this paper
• Hydrogen-rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus-activated kinase 2/signal transducer and activator of transcription 3 signaling pathway

  2018cites this paper
• Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A

  2018cites this paper
• The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma

  2018cites this paper
• Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells

  2018cites this paper
• High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer

  2018cites this paper
• P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer.

  2017cites this paper
• P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer

  2017cites this paper